Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes

被引：0
|
作者：
Yayoi Nishida
Yasuo Takahashi
Tomohiro Nakayama
Satoshi Asai
机构：
[1] Nihon University School of Medicine,Division of Genomic Epidemiology and Clinical Trials, Advanced Medical Research Center
[2] Nihon University School of Medicine,Division of Clinical Trial Management, Advanced Medical Research Center
[3] Nihon University School of Medicine,Division of Pharmacology, Department of Biomedical Sciences
[4] Nihon University School of Medicine,Division of Laboratory Medicine, Department of Pathology and Microbiology
来源：
Cardiovascular Diabetology | / 11卷
关键词：
Angiotensin II receptor blocker (ARB); Calcium channel blocker (CCB); Hematological parameter; Retrospective observational study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients
    Yamamoto, S
    Kawashima, T
    Kunitake, T
    Koide, S
    Fujimoto, H
    BLOOD PRESSURE, 2003, 12 : 22 - 28
  • [42] Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers
    Kintscher, U
    Unger, T
    ACTA DIABETOLOGICA, 2005, 42 (Suppl 1) : S26 - S32
  • [43] The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus
    Mathur, G.
    Noronha, B.
    Rodrigues, E.
    Davis, G.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 617 - 629
  • [44] Adverse effects of angiotensin II type 1 receptor blockers
    Preobrazhensky, DV
    Sidorenko, BA
    KARDIOLOGIYA, 2002, 42 (03) : 88 - 94
  • [45] Sudden collapses in the heat in patients on angiotensin type 2 receptor blockers
    Radford, P. J.
    RURAL AND REMOTE HEALTH, 2014, 14 (02):
  • [46] Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers
    U. Kintscher
    T. Unger
    Acta Diabetologica, 2005, 42 : s26 - s32
  • [47] The antineoplastic effects of angiotensin II type 1 receptor blockers
    Kapoor, Shailendra
    JOURNAL OF HYPERTENSION, 2013, 31 (01) : 217 - 217
  • [48] ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITH CANCER RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Lin, Jou-Wei
    Chang, Chia-Hsuin
    Lai, Mei-Shu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E489 - E489
  • [49] Clinical comparative trials of angiotensin II type 1 (AT1)-receptor blockers
    Meredith, PA
    BLOOD PRESSURE, 2001, 10 : 11 - 17
  • [50] Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy
    Ravera, Maura
    Re, Michela
    Vettoretti, Simone
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : S44 - S48
12345